Hot Features
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology... Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.3 | 27.3684210526 | 4.75 | 6.0418 | 4.75 | 119493 | 5.69325073 | CS |
| 4 | 5.83 | 2650 | 0.22 | 7.05 | 0.1103 | 10545941 | 0.40525572 | CS |
| 12 | 4.82 | 391.869918699 | 1.23 | 7.05 | 0.1103 | 14073159 | 0.28369475 | CS |
| 26 | 5.9603 | 6644.70457079 | 0.0897 | 7.05 | 0.0462 | 16261876 | 0.20549414 | CS |
| 52 | 5.664 | 1467.35751295 | 0.386 | 7.05 | 0.0462 | 19760360 | 0.2575344 | CS |
| 156 | 4.21 | 228.804347826 | 1.84 | 7.05 | 0.0462 | 17782724 | 0.31632227 | CS |
| 260 | 4.21 | 228.804347826 | 1.84 | 7.05 | 0.0462 | 17782724 | 0.31632227 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.